UniProt ID | AT1B1_HUMAN | |
---|---|---|
UniProt AC | P05026 | |
Protein Name | Sodium/potassium-transporting ATPase subunit beta-1 | |
Gene Name | ATP1B1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 303 | |
Subcellular Localization |
Cell membrane Single-pass type II membrane protein . Cell membrane, sarcolemma . Colocalizes with OBSCN at the intercalated disk and sarcolemma in cardiomyocytes. Localizes in long striations at the level of Z and M lines. |
|
Protein Description | This is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of Na(+) and K(+) ions across the plasma membrane. The beta subunit regulates, through assembly of alpha/beta heterodimers, the number of sodium pumps transported to the plasma membrane.; Involved in cell adhesion and establishing epithelial cell polarity.. | |
Protein Sequence | MARGKAKEEGSWKKFIWNSEKKEFLGRTGGSWFKILLFYVIFYGCLAGIFIGTIQVMLLTISEFKPTYQDRVAPPGLTQIPQIQKTEISFRPNDPKSYEAYVLNIVRFLEKYKDSAQRDDMIFEDCGDVPSEPKERGDFNHERGERKVCRFKLEWLGNCSGLNDETYGYKEGKPCIIIKLNRVLGFKPKPPKNESLETYPVMKYNPNVLPVQCTGKRDEDKDKVGNVEYFGLGNSPGFPLQYYPYYGKLLQPKYLQPLLAVQFTNLTMDTEIRIECKAYGENIGYSEKDRFQGRFDVKIEVKS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | GKAKEEGSWKKFIWN CCCCCCCCCCCEEEE | 38.71 | 28348404 | |
13 | 2-Hydroxyisobutyrylation | AKEEGSWKKFIWNSE CCCCCCCCCEEEECH | 39.23 | - | |
13 | Ubiquitination | AKEEGSWKKFIWNSE CCCCCCCCCEEEECH | 39.23 | - | |
14 | Ubiquitination | KEEGSWKKFIWNSEK CCCCCCCCEEEECHH | 35.50 | - | |
21 | Ubiquitination | KFIWNSEKKEFLGRT CEEEECHHHHHHCCC | 58.38 | - | |
85 | Ubiquitination | TQIPQIQKTEISFRP CCCCCCEEEEEEECC | 50.16 | - | |
96 | Ubiquitination | SFRPNDPKSYEAYVL EECCCCCCHHHHHHH | 69.41 | - | |
96 (in isoform 2) | Ubiquitination | - | 69.41 | - | |
97 | Phosphorylation | FRPNDPKSYEAYVLN ECCCCCCHHHHHHHH | 33.33 | 28152594 | |
98 | Phosphorylation | RPNDPKSYEAYVLNI CCCCCCHHHHHHHHH | 15.65 | 28152594 | |
101 | Phosphorylation | DPKSYEAYVLNIVRF CCCHHHHHHHHHHHH | 8.11 | 22817900 | |
113 | 2-Hydroxyisobutyrylation | VRFLEKYKDSAQRDD HHHHHHHHHHHCCCC | 57.16 | - | |
113 | Ubiquitination | VRFLEKYKDSAQRDD HHHHHHHHHHHCCCC | 57.16 | - | |
118 | Methylation | KYKDSAQRDDMIFED HHHHHHCCCCCEEEC | 41.43 | - | |
118 | Dimethylation | KYKDSAQRDDMIFED HHHHHHCCCCCEEEC | 41.43 | - | |
121 | Sulfoxidation | DSAQRDDMIFEDCGD HHHCCCCCEEECCCC | 4.41 | 28465586 | |
134 | Ubiquitination | GDVPSEPKERGDFNH CCCCCCCHHCCCCCC | 56.86 | - | |
147 | Ubiquitination | NHERGERKVCRFKLE CCCCCCCEEEEEEEE | 41.19 | - | |
152 | Ubiquitination | ERKVCRFKLEWLGNC CCEEEEEEEEECCCC | 26.58 | - | |
158 | N-linked_Glycosylation | FKLEWLGNCSGLNDE EEEEECCCCCCCCCC | 18.01 | 12754519 | |
170 | Ubiquitination | NDETYGYKEGKPCII CCCCCCCCCCCEEEE | 56.48 | - | |
173 | Ubiquitination | TYGYKEGKPCIIIKL CCCCCCCCEEEEEEE | 37.50 | - | |
179 | Ubiquitination | GKPCIIIKLNRVLGF CCEEEEEEECCCCCC | 29.33 | - | |
187 | Ubiquitination | LNRVLGFKPKPPKNE ECCCCCCCCCCCCCC | 50.78 | - | |
193 | N-linked_Glycosylation | FKPKPPKNESLETYP CCCCCCCCCCCCCCC | 50.27 | 12754519 | |
195 | Phosphorylation | PKPPKNESLETYPVM CCCCCCCCCCCCCEE | 40.68 | 30242111 | |
198 | Phosphorylation | PKNESLETYPVMKYN CCCCCCCCCCEEECC | 38.12 | 30242111 | |
199 | Phosphorylation | KNESLETYPVMKYNP CCCCCCCCCEEECCC | 5.62 | 30242111 | |
216 | Ubiquitination | LPVQCTGKRDEDKDK ECEECCCCCCCCCCC | 38.22 | - | |
216 | 2-Hydroxyisobutyrylation | LPVQCTGKRDEDKDK ECEECCCCCCCCCCC | 38.22 | - | |
221 | Ubiquitination | TGKRDEDKDKVGNVE CCCCCCCCCCCCCEE | 58.35 | - | |
223 | Ubiquitination | KRDEDKDKVGNVEYF CCCCCCCCCCCEEEE | 58.75 | - | |
229 | Phosphorylation | DKVGNVEYFGLGNSP CCCCCEEEEECCCCC | 9.92 | 29978859 | |
235 | Phosphorylation | EYFGLGNSPGFPLQY EEEECCCCCCCCCHH | 25.30 | 29978859 | |
242 | Phosphorylation | SPGFPLQYYPYYGKL CCCCCCHHHCCCCEE | 17.68 | 29978859 | |
243 | Phosphorylation | PGFPLQYYPYYGKLL CCCCCHHHCCCCEEC | 3.33 | 29978859 | |
245 | Phosphorylation | FPLQYYPYYGKLLQP CCCHHHCCCCEECCH | 14.55 | 29978859 | |
246 | Phosphorylation | PLQYYPYYGKLLQPK CCHHHCCCCEECCHH | 11.86 | 29978859 | |
248 (in isoform 2) | Ubiquitination | - | 29.87 | - | |
248 | Ubiquitination | QYYPYYGKLLQPKYL HHHCCCCEECCHHHH | 29.87 | - | |
254 | Phosphorylation | GKLLQPKYLQPLLAV CEECCHHHHHHEEEE | 19.77 | - | |
265 | N-linked_Glycosylation | LLAVQFTNLTMDTEI EEEEEEECCCCCCEE | 34.50 | 12754519 | |
265 | N-linked_Glycosylation | LLAVQFTNLTMDTEI EEEEEEECCCCCCEE | 34.50 | 19522481 | |
277 | Ubiquitination | TEIRIECKAYGENIG CEEEEEEEECCCCCC | 31.67 | - | |
285 | Phosphorylation | AYGENIGYSEKDRFQ ECCCCCCCCHHHCCC | 15.17 | - | |
288 | Ubiquitination | ENIGYSEKDRFQGRF CCCCCCHHHCCCCEE | 48.54 | - | |
288 | 2-Hydroxyisobutyrylation | ENIGYSEKDRFQGRF CCCCCCHHHCCCCEE | 48.54 | - | |
288 | Acetylation | ENIGYSEKDRFQGRF CCCCCCHHHCCCCEE | 48.54 | 27452117 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AT1B1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AT1B1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
D00112 | G-Strophanthin (JAN); Ouabain; Ouabain octahydrate | |||||
D00297 | Digitoxin (JP16/USP/INN); Crystodigin (TN) | |||||
D00298 | Digoxin (JP16/USP); Lanoxicaps (TN); Lanoxin (TN) | |||||
D01240 | Deslanoside (JP16/USP/INN); Cedilanid-d (TN) | |||||
D01379 | Proscillaridin (JAN/USAN/INN); Talusin (TN) | |||||
D01972 | Lanatoside C (JP16/INN); Digilanogen C (TN) | |||||
D02587 | Metildigoxin (JP16); Lanirapid (TN) | |||||
D06881 | Acetyldigitoxin (INN); Acylanid (TN) | |||||
D07147 | Gitoformate (INN) | |||||
D07555 | Acetyldigoxin; Cedigossima (TN) | |||||
D07556 | beta-Acetyldigoxin; Acetyldigoxin beta isomer; Corotal (TN) | |||||
D09847 | Metildigoxin (INN); Medigoxin (BAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-265, AND MASSSPECTROMETRY. | |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-158; ASN-193 AND ASN-265,AND MASS SPECTROMETRY. | |
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry."; Zhang H., Li X.-J., Martin D.B., Aebersold R.; Nat. Biotechnol. 21:660-666(2003). Cited for: GLYCOSYLATION AT ASN-158; ASN-193 AND ASN-265. |